Review
Open access
Jul 2026
New Paradigms in Management of Central Nervous System Damage in Patients with Hunter Syndrome
Development of pabinafusp alfa (JR-141), innovative drug penetrating the BBB via transcytosis mediated by the transferrin receptor, became one of the approaches to solve this problem.
N. D. Vashakmadze, N. V. Zhurkova, L. Tsyngunova et al.
· Current Pediatrics · 0 citations